Brief: Verve Therapeutics Q2 EPS USD -0.87
10/08/2023 11:33
Aug 10 (Reuters) - Verve Therapeutics Q2 collaboration revenue USD 2.093 million. * Q2 net income USD -53.983 million * Q2 EPS USD -0.87
- $992.16m
- $495.09m
- $32.33m
Aug 10 (Reuters) - Verve Therapeutics Q2 collaboration revenue USD 2.093 million. * Q2 net income USD -53.983 million * Q2 EPS USD -0.87